Time-course MALDI-TOF-MS serum peptide profiling of non-small cell lung cancer patients treated with bortezomib, cisplatin and gemcitabine

J. Voortman, T. V. Pham, J. C. Knol, G. Giaccone, C. R. Jimenez

Research output: Contribution to journalMeeting AbstractAcademic

Original languageEnglish
JournalJournal of Clinical Oncology
Issue number15
Publication statusPublished - 20 May 2008

Cite this